Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
BioMed X
BioMed X
Activities:
Training & Education
Research & Development
X
LinkedIn
Trending Articles
Life sciences sector hit with funding cuts, but novel report highlights feasible industry solutions
The review highlights the recent investment reductions observed within the life sciences industry, and why its important to support smaller businesses to develop their innovations
Enhancing sterility: the crucial role of isolators in sterile fill-finish
Maintaining the highest levels of sterility is paramount to ensure the safety and efficacy of drugs, with good aseptic manufacturing practices playing a pivotal role in...
Making the most of each cell: single-use perfusion in biopharma processing
GEA kytero perfusion disk stack separators are pioneering the time- and cost-efficient harvesting of pharmaceutical proteins from cells and facilitating continuous processing,...
Teva & Medincell release Phase III SOLARIS trial results for olanzapine in schizophrenic adults
The results indicate that Medincell's TEV-'749 subcutaneous extended release device for the administration of olanzapine in schizophrenic adults met primary and secondary...
DevPro Biopharma and Bespak complete early studies for novel sustainable albuterol inhaler
The novel formulation exhibits a low global warming potential (GWP) and shows comparable performance to Ventolin HFA
Upcoming event
BIO International Convention Digital
3-6 June, 2024 | Convention | San Diego, US
See all
Related Content
Research & Development
BioMed X Institute and Merck begin second immunology project
Team TDA will join the three ongoing research groups sponsored by Merck, which follow four completed projects
Research & Development
BioMed X and Boehringer Ingelheim initiate brain sensor project
Two projects are already underway between the research partners, including one in immunology and one in neuroscience
Research & Development
BioMed X completes fourth oncology project with Merck
The next project team: “Synthetic Lethality in DNA Repair” (SDR) is led by Dr Özdemirhan Serçin, who was a postdoctoral researcher in the DDC teamv
Research & Development
BioMed X and Janssen R&D announce two research groups
The groups will explore research related to autoimmunity and drug delivery
Research & Development
BioMed X and Merck launch oncology research programme
The key aim of the project will be to generate a comprehensive atlas of extrachromosomal DNA in human cancer tissues
Research & Development
BioMed X and Merck extend research collaboration
The two entered a partnership in 2013 and the resulting research has led to 25 scientific publications
Research & Development
BioMed X begins research project for oral therapeutics delivery
The collaboration with Janssen Research and Development was facilitated by Johnson & Johnson Innovation
Subscribe now